APA

Radovich M., Kiel P. J., Nance S. M., Niland E. E., Parsley M. E., Ferguson M. E., Jiang G., Ammakkanavar N. R., Einhorn L. H., Cheng L., Nassiri M., Davidson D. D., Rushing D. A., Loehrer P. J., Pili R., Hanna N., Callaghan J. T., Skaar T. C., Helft P. R., Shahda S., O'Neil B. H. & Schneider B. P. (20180220). Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers. : Oncotarget.

Chicago

Radovich Milan, Kiel Patrick J, Nance Stacy M, Niland Erin E, Parsley Megan E, Ferguson Meagan E, Jiang Guanglong, Ammakkanavar Natraj R, Einhorn Lawrence H, Cheng Liang, Nassiri Mehdi, Davidson Darrell D, Rushing Daniel A, Loehrer Patrick J, Pili Roberto, Hanna Nasser, Callaghan J Thomas, Skaar Todd C, Helft Paul R, Shahda Safi, O'Neil Bert H and Schneider Bryan P. 20180220. Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers. : Oncotarget.

Harvard

Radovich M., Kiel P. J., Nance S. M., Niland E. E., Parsley M. E., Ferguson M. E., Jiang G., Ammakkanavar N. R., Einhorn L. H., Cheng L., Nassiri M., Davidson D. D., Rushing D. A., Loehrer P. J., Pili R., Hanna N., Callaghan J. T., Skaar T. C., Helft P. R., Shahda S., O'Neil B. H. and Schneider B. P. (20180220). Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers. : Oncotarget.

MLA

Radovich Milan, Kiel Patrick J, Nance Stacy M, Niland Erin E, Parsley Megan E, Ferguson Meagan E, Jiang Guanglong, Ammakkanavar Natraj R, Einhorn Lawrence H, Cheng Liang, Nassiri Mehdi, Davidson Darrell D, Rushing Daniel A, Loehrer Patrick J, Pili Roberto, Hanna Nasser, Callaghan J Thomas, Skaar Todd C, Helft Paul R, Shahda Safi, O'Neil Bert H and Schneider Bryan P. Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers. : Oncotarget. 20180220.